SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001645113-20-000079
Filing Date
2020-05-12
Accepted
2020-05-12 16:22:54
Documents
2
Period of Report
2020-05-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_158931495360958.html 4  
1 FORM 4 wf-form4_158931495360958.xml 4 7083
2 POWER OF ATTORNEY - EBENAIM- 2020-02-26 ex-24.htm EX-24 4981
  Complete submission text file 0001645113-20-000079.txt   13557
Mailing Address C/O REXAHN PHARMACEUTICALS, INC. 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address
Benaim Ely (Reporting) CIK: 0001632237 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37565 | Film No.: 20869398

Mailing Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF
Business Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF 44 (0)15 3475 6700
NovoCure Ltd (Issuer) CIK: 0001645113 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus